ArticleBMJ open2026
Optimising graft selection in ACL reconstruction (GRASE ACL): a study protocol for a randomised controlled clinical trial investigating quadriceps, hamstring and patella tendon for reconstruction in patients with primary ACL rupture.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05342441 (Optimizing GRAft SElection for ACL Reconstruction), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Optimizing GRAft SElection for ACL Reconstruction (GRASE-ACL Trial) - a Three-armed Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAnterior cruciate ligament (ACL) reconstruction (ACL-R) is recommended for active patients aiming to return to demanding sports or occupations after ACL rupture. Primary graft options are bone-patellar tendon-bone (BPTB), hamstring tendons (HT) and quadriceps tendon (QT) autografts. However, consensus regarding the optimal graft remains lacking. This trial compares graft selection effects on patient-reported knee function and neuromuscular control after ACL-R. METHODS AND ANALYSIS: The GRASE ACL trial is a single-centre assessor-blinded randomised controlled trial with a three-group parallel design conducted at Copenhagen University Hospital Amager-Hvidovre, Denmark. A total of 150 patients aged 18-40 years with primary ACL rupture are randomised in a 1:1:1 ratio to ACL-R using BPTB, HT or QT autografts. Recruitment was completed in August 2025.The trial uses a dual-primary-outcomes framework evaluated at 12 months. The primary patient-reported outcome is the International Knee Documentation Committee Evaluation Form score, analysed within a non-inferiority framework. The primary biomechanical outcome is the Limb Symmetry Index of Rate of Torque Development (RTD-LSI) during isometric knee flexion, analysed within a superiority framework.Secondary outcomes include patient-reported knee function, return-to-sport and return-to-work outcomes, neuromuscular control, muscle strength, movement biomechanics, clinical knee stability, adverse events and MRI-assessed muscle morphology. Assessments occur at 1, 6, 12, and 24 months postoperatively. ETHICS AND DISSEMINATION: This trial has been approved by the scientific ethics committee for the Capital Region of Denmark and conducted in accordance with the Declaration of Helsinki. Reporting will adhere to Consolidated Standards of Reporting Trials (CONSORT) guidelines and disseminated through peer-reviewed publications and ClinicalTrials.gov updates.
trial registrationClinicalTrials.gov: NCT05342441, protocol V.1.5, 24 September 2025, https://clinicaltrials.gov/study/NCT05342441.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.